Nephrectomy versus no nephrectomy for metastatic renal carcinoma

ISRCTN ISRCTN75184582
DOI https://doi.org/10.1186/ISRCTN75184582
Secondary identifying numbers RE03
Submission date
28/02/2001
Registration date
28/02/2001
Last edited
26/02/2016
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Cancer
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Pat Cook
Scientific

MRC Clinical Trials Unit
222 Euston Road
London
NW1 2DA
United Kingdom

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Scientific titleNephrectomy versus no nephrectomy for metastatic renal carcinoma
Study objectivesTo establish whether, in patients with metastatic renal carcinoma, nephrectomy has any advantage.
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedRenal Cancer
Intervention1. One group receives a nephrectomy
2. The other receives no nephrectomy
Intervention typeOther
Primary outcome measure1. Time to progression
2. Metastase rate
3. Quality of life
4. Survival time
Secondary outcome measuresNot provided at time of registration
Overall study start date01/01/1995
Completion date01/12/1998

Eligibility

Participant type(s)Patient
Age groupNot Specified
SexNot Specified
Target number of participants120
Key inclusion criteria1. Patient should have locally operable disease and should be fit enough for nephrectomy
2. A renal tumour with clinical or radiological evidence of metastases
3. No previous malignancy (except non-melanotic skin cancer or in situ carcinoma of the cervix)
4. Written informed consent of the patient
Key exclusion criteriaNot provided at time of registration
Date of first enrolment01/01/1995
Date of final enrolment01/12/1998

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

MRC Clinical Trials Unit
London
NW1 2DA
United Kingdom

Sponsor information

Medical Research Council (MRC) (UK)
Research council

20 Park Crescent
London
W1B 1AL
United Kingdom

Phone +44 (0)20 7636 5422
Email clinical.trial@headoffice.mrc.ac.uk
Website http://www.mrc.ac.uk

Funders

Funder type

Research council

Medical Research Council (MRC) (UK)
Government organisation / National government
Alternative name(s)
Medical Research Council (United Kingdom), UK Medical Research Council, MRC
Location
United Kingdom

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Editorial Notes

26/02/2016: No publications found, study status unverified.